Cochlear Limited Wins Four Awards for Healthcare Innovation
'Technologic Innovation Is the Turbo-Charger of Growth.' -- Chris Roberts, Cochlear CEO
SYDNEY, AUSTRALIA--(Marketwired - Sep 26, 2013) - Cochlear Limited (ASX: COH) has been awarded a series of prestigious international design awards for two of its latest product innovations.
The Cochlear(TM) Nucleus(R) CR120 Intraoperative Remote Assistant and Cochlear(TM) Nucleus(R) CR110 Remote Assistant Fitting, have won four design excellence awards between them.
Both products are part of a range of advanced clinical care tools developed by Cochlear to revolutionise treatment pathways for cochlear implantation. By using some of the industry's most advanced technologies and making them easier to use, the products help healthcare professionals look after cochlear implant recipients. They automate some of the more time consuming tasks carried out by audiologists and surgeons from surgery onward.
COH Price at posting:
$61.50 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)